Prosensa Holding N.V. (RNA) Tops Q2 EPS by 13c

Prosensa Holding N.V. (NASDAQ: RNA) reported Q2 EPS of ($0.66), $0.13 better than the analyst estimate of ($0.79). Revenue for the quarter came in at $2.32 million versus the consensus estimate of $2.14 million.

For earnings history and earnings-related data on Prosensa Holding N.V. (RNA) click here.

You May Also Be Interested In

• Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c